Paul Hastings LLP advised BofA Securities as the sole placement agent in connection with Century Therapeutics’ private placement (PIPE). Century Therapeutics (Nasdaq: IPSC) is a biotechnology company developing induced pluripotent stem cell (iPSC)-derived therapies in immune-oncology and autoimmune and inflammatory diseases. 

Partner and Co-head of Equity Capital Markets and Co-chair of the Corporate Life Sciences Group Seo Salimi and Securities and Capital Markets partner Will Magioncalda led the Paul Hastings team, which also included associate Lauren Zhang.

More details on the transaction can be found here.

About Paul Hastings

With widely recognized elite teams in finance, mergers & acquisitions, private equity, restructuring and special situations, litigation, employment, and real estate, Paul Hastings is a premier law firm providing intellectual capital and superior execution globally to the world’s leading investment banks, asset managers, and corporations.